Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Benz

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 2026
Fibroblast Activation Protein-Targeted Radiopharmaceutical Therapy Using <sup>177</sup>Lu-, <sup>90</sup>Y-, and <sup>225</sup>Ac-Labeled 3BP-3940: First Experience in 21 Different Advanced MalignanciesRichard P Baum, Tianzhi Zhao, Vivianne Jakobsson, et al.
Seminars in Nuclear Medicine|July 17, 2024
Radiomolecular Theranostics With Fibroblast-Activation-Protein Inhibitors and PeptidesRichard P Baum, Emil Novruzov, Tianzhi Zhao, et al.
Environmental and Molecular Mutagenesis|September 22, 2016
Next generation testing strategy for assessment of genomic damage: A conceptual framework and considerationsKerry L Dearfield, B Bhaskar Gollapudi, Jeffrey C Bemis, et al.
Environmental and Molecular Mutagenesis|August 27, 2010
New and emerging technologies for genetic toxicity testingAnthony M Lynch, Jennifer C Sasaki, Rosalie Elespuru, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 2026
Fibroblast Activation Protein-Targeted Radiopharmaceutical Therapy Using <sup>177</sup>Lu-, <sup>90</sup>Y-, and <sup>225</sup>Ac-Labeled 3BP-3940: First Experience in 21 Different Advanced MalignanciesRichard P Baum, Tianzhi Zhao, Vivianne Jakobsson, et al.
Seminars in Nuclear Medicine|July 17, 2024
Radiomolecular Theranostics With Fibroblast-Activation-Protein Inhibitors and PeptidesRichard P Baum, Emil Novruzov, Tianzhi Zhao, et al.
Environmental and Molecular Mutagenesis|September 22, 2016
Next generation testing strategy for assessment of genomic damage: A conceptual framework and considerationsKerry L Dearfield, B Bhaskar Gollapudi, Jeffrey C Bemis, et al.
Environmental and Molecular Mutagenesis|August 27, 2010
New and emerging technologies for genetic toxicity testingAnthony M Lynch, Jennifer C Sasaki, Rosalie Elespuru, et al.
Pageof 4